Veterinary Medicines

Equip EHV 1,4 Suspension for injection

Authorised
  • Equine herpesvirus 1, strain 438/77, Inactivated
  • Equine herpesvirus 4, strain 405/76, Inactivated
Download as PDF

Product identification

Medicine name:
Equip EHV 1,4 Suspension for injection
Active substance:
  • Equine herpesvirus 1, strain 438/77, Inactivated
  • Equine herpesvirus 4, strain 405/76, Inactivated
Target species:
  • Horse
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Equine herpesvirus 1, strain 438/77, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Equine herpesvirus 4, strain 405/76, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI05AA05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Single dose vials (1.5 ml)Closure:Chlorobutyl rubber stopper Ph Eur. Aluminium crimp cap.Vial:Type I (Ph.Eur.) glass.3 ml capacityThe vaccine is presented in cartons containing 10 doses
  • Single dose vials (1.5 ml)Closure:Chlorobutyl rubber stopper Ph Eur. Aluminium crimp cap.Vial:Type I (Ph.Eur.) glass.3 ml capacityThe vaccine is presented in cartons containing 3 doses
  • Single dose vials (1.5 ml)Closure:Chlorobutyl rubber stopper Ph Eur. Aluminium crimp cap.Vial:Type I (Ph.Eur.) glass.3 ml capacityThe vaccine is presented in cartons containing 2 doses
  • Single dose vials (1.5 ml)Closure:Chlorobutyl rubber stopper Ph Eur. Aluminium crimp cap.Vial:Type I (Ph.Eur.) glass.3 ml capacityThe vaccine is presented in cartons containing 1 dose

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
  • Zoetis Belgium
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10387/028/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 5/01/2025
Download